Specialty Pharma Journal Specialty, Precision & Technology
GAITHERSBURG, Md. and SAINT-HERBLAIN, France, Nov. 19, 2018 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) and Valneva SE (VLA) today announced positive interim results for the Phase 1 study evaluating VLA1601, their vaccine candidate against the Zika virus. The highly purified inactivated vaccine candidate, VLA1601, met the study’s primary …
Tag Archives: Zika virus
November, 2018
October, 2017
-
6 October
FDA Approves Test for Screening Zika Virus in Blood Donations
The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors. It is intended for use by blood …
November, 2016
-
17 November
FDA Research to Help Speed Development of Zika Virus Vaccines and Therapeutics
A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics. Published today in PLoS Pathogens, is the description of a neonatal mouse model that provides a platform for potentially improving and expediting studies …
October, 2016
-
17 October
Scientists Uncover New Facets of Zika-Related Birth Defects
JUPITER, FL – Oct. 17, 2016 – In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute (TSRI) have elucidated how the virus attacks the brains of newborns, information that could accelerate the …
September, 2016
-
2 September
Takeda to Develop Zika Vaccine with up to $312 Million in Funding from US Government
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that BARDA, the Biomedical Advanced Research and Development Authority, has selected Takeda’s Vaccine Business Unit to develop a vaccine to support the Zika response in the US and affected regions around the world. Initial funding from BARDA, which is …
August, 2016
-
29 August
FDA Advises Testing for Zika Virus in all Donated Blood and Blood Components in the US
As a further safety measure against the emerging Zika virus outbreak, today the U.S. Food and Drug Administration issued a revised guidance recommending universal testing of donated Whole Blood and blood components for Zika virus in the U.S. and its territories. “There is still much uncertainty regarding the nature and …
-
26 August
Special Report Documents Zika Virus’ Impact on the Fetal Brain
BOSTON – In a special report released August 23 in the journal Radiology, a team of researchers including Deborah Levine, MD, Director of Obstetric & Gynecologic ultrasound at Beth Israel Deaconess Medical Center (BIDMC) and professor of radiology at Harvard Medical School (HMS), documented the brain abnormalities associated with congenital …
-
19 August
Xenetic Biosciences Partners with Excivion for Development of Novel Combined Zika and Dengue Vaccine
LEXINGTON, Mass.–(BUSINESS WIRE)–Xenetic Biosciences, Inc. (OTCQB: XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company developing next-generation biologic drugs and novel orphan oncology therapeutics, today announced that it has commenced a collaboration with Excivion Ltd. (“Excivion”) to develop a vaccine against Zika and dengue viruses. As part of the collaboration, Xenetic’s …
June, 2016
-
20 June
Hologic and Grifols’ Zika Virus Assay Granted FDA Emergency Use Authorization
MARLBOROUGH, Mass. and EMERYVILLE, Calif., June 20, 2016 /PRNewswire/ — Hologic, Inc. (NASDAQ: HOLX) and Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) – market-leading partners committed to blood safety – announced today that the U.S. Food and Drug Administration (FDA) has approved use of the Procleix Zika virus blood …
May, 2016
-
16 May
U.S. CDC Announces Funds to Prepare for Zika Locally
ATLANTA, May 13, 2016 /PRNewswire-USNewswire/ — U.S. states and territories can now apply to CDC for funds to fight Zika locally. More than $85 million in redirected funds identified by the Department of Health and Human Services is being made available to support efforts to protect Americans from Zika infection …